{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:42:44Z","timestamp":1778496164622,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,20]]},"DOI":"10.7759\/cureus.16503","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T11:24:11Z","timestamp":1626780251000},"source":"Crossref","is-referenced-by-count":9,"title":["Fecal Microbiota Transplantation: A Microbiome Modulation Technique for Alzheimer\u2019s Disease"],"prefix":"10.7759","author":[{"given":"Varsha","family":"Nandwana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shibajee","family":"Debbarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"Carabotti M","year":"2015","unstructured":"Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015, 28:203-9.","journal-title":"Ann Gastroenterol"},{"key":"ref2","article-title":"Gut bacteria in health and disease","volume":"9","author":"Quigley EM","year":"2013","unstructured":"Quigley EM. Gut bacteria in health and disease. Gastroenterol Hepatol (N Y). 2013, 9:560-9.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2013.848793","article-title":"The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes","volume":"9","author":"Bekkering P","year":"2013","unstructured":"Bekkering P, Jafri I, van Overveld FJ, Rijkers GT. The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes. Expert Rev Clin Immunol. 2013, 9:1031-41. 10.1586\/1744666X.2013.848793","journal-title":"Expert Rev Clin Immunol"},{"key":"ref4","unstructured":"World Alzheimer Report 2015. The global impact of dementia. an analysis of prevalence, incidence, cost and trends. (2015). Accessed: June 07, 2021: https:\/\/www.alzint.org\/resource\/world-alzheimer-report-2015\/."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2019.01.010","article-title":"2019 Alzheimer's disease facts and figures","volume":"15","author":"Gaugler J","year":"2019","unstructured":"Gaugler J, James B, Johnson T, Marin A, Weuve J. 2019 Alzheimer's disease facts and figures. Alzheimer Dement. 2019, 15:321-87. 10.1016\/j.jalz.2019.01.010","journal-title":"Alzheimer Dement"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000027","article-title":"Therapeutic faecal microbiota transplantation: current status and future developments","volume":"30","author":"Borody TJ","year":"2014","unstructured":"Borody TJ, Brandt LJ, Paramsothy S. Therapeutic faecal microbiota transplantation: current status and future developments. Curr Opin Gastroenterol. 2014, 30:97-105. 10.1097\/MOG.0000000000000027","journal-title":"Curr Opin Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112358","article-title":"The microbiota-gut-brain axis and Alzheimer disease. From dysbiosis to neurodegeneration: focus on the central nervous system glial cells","volume":"10","author":"Giovannini MG","year":"2021","unstructured":"Giovannini MG, Lana D, Traini C, Vannucchi MG. The microbiota-gut-brain axis and Alzheimer disease. From dysbiosis to neurodegeneration: focus on the central nervous system glial cells. J Clin Med. 2021, 10:2358. 10.3390\/jcm10112358","journal-title":"J Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S200490","article-title":"Alzheimer's disease: pathogenesis, diagnostics, and therapeutics","volume":"14","author":"Tiwari S","year":"2019","unstructured":"Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M. Alzheimer's disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine. 2019, 14:5541-54. 10.2147\/IJN.S200490","journal-title":"Int J Nanomedicine"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00378-4","article-title":"Microbial involvement in Alzheimer disease development and progression","volume":"15","author":"Bulgart HR","year":"2020","unstructured":"Bulgart HR, Neczypor EW, Wold LE, Mackos AR. Microbial involvement in Alzheimer disease development and progression. Mol Neurodegener. 2020, 15:42. 10.1186\/s13024-020-00378-4","journal-title":"Mol Neurodegener"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i30.5486","article-title":"Influence of gut microbiota on neuropsychiatric disorders","volume":"23","author":"Cenit MC","year":"2017","unstructured":"Cenit MC, Sanz Y, Codo\u00f1er-Franch P. Influence of gut microbiota on neuropsychiatric disorders. World J Gastroenterol. 2017, 23:5486-98. 10.3748\/wjg.v23.i30.5486","journal-title":"World J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-020-01024-9","article-title":"Dysbiosis and Alzheimer's disease: cause or treatment opportunity? [In Press]","author":"Janeiro MH","year":"2021","unstructured":"Janeiro MH, Ram\u00edrez MJ, Solas M. Dysbiosis and Alzheimer's disease: cause or treatment opportunity? [In Press]. Cell Mol Neurobiol. 2021, 10.1007\/s10571-020-01024-9","journal-title":"Cell Mol Neurobiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00269","article-title":"Luminal conversion and immunoregulation by probiotics","volume":"6","author":"Ganesh BP","year":"2015","unstructured":"Ganesh BP, Versalovic J. Luminal conversion and immunoregulation by probiotics. Front Pharmacol. 2015, 6:269. 10.3389\/fphar.2015.00269","journal-title":"Front Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2019.1638722","article-title":"Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health","volume":"11","author":"Parker A","year":"2020","unstructured":"Parker A, Fonseca S, Carding SR. Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. Gut Microbes. 2020, 11:135-57. 10.1080\/19490976.2019.1638722","journal-title":"Gut Microbes"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2016.08.019","article-title":"Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly","volume":"49","author":"Cattaneo A","year":"2017","unstructured":"Cattaneo A, Cattane N, Galluzzi S, et al.. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017, 49:60-8. 10.1016\/j.neurobiolaging.2016.08.019","journal-title":"Neurobiol Aging"},{"key":"ref15","article-title":"The gut microbiome & its value in autoimmune diseases","author":"Glass P","year":"2021","unstructured":"Glass P. The gut microbiome & its value in autoimmune diseases. Baylor University, Waco, TX; 2021."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13601-y","article-title":"Gut microbiome alterations in Alzheimer's disease","volume":"7","author":"Vogt NM","year":"2017","unstructured":"Vogt NM, Kerby RL, Dill-McFarland KA, et al.. Gut microbiome alterations in Alzheimer's disease. Sci Rep. 2017, 7:13537. 10.1038\/s41598-017-13601-y","journal-title":"Sci Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/lam.12882","article-title":"Shifts in gut microbiota composition in an APP\/PSS1 transgenic mouse model of Alzheimer's disease during lifespan","volume":"66","author":"B\u00e4uerl C","year":"2018","unstructured":"B\u00e4uerl C, Collado MC, Diaz Cuevas A, Vi\u00f1a J, P\u00e9rez Mart\u00ednez G. Shifts in gut microbiota composition in an APP\/PSS1 transgenic mouse model of Alzheimer's disease during lifespan. Lett Appl Microbiol. 2018, 66:464-71. 10.1111\/lam.12882","journal-title":"Lett Appl Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-54187-x","article-title":"Calorie restriction slows age-related microbiota changes in an Alzheimer's disease model in female mice","volume":"9","author":"Cox LM","year":"2019","unstructured":"Cox LM, Schafer MJ, Sohn J, Vincentini J, Weiner HL, Ginsberg SD, Blaser MJ. Calorie restriction slows age-related microbiota changes in an Alzheimer's disease model in female mice. Sci Rep. 2019, 9:17904. 10.1038\/s41598-019-54187-x","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15571","article-title":"Microbiota modulation as preventative and therapeutic approach in Alzheimer\u2019s disease","volume":"288","author":"Bonfili L","year":"2021","unstructured":"Bonfili L, Cecarini V, Gogoi O, et al.. Microbiota modulation as preventative and therapeutic approach in Alzheimer\u2019s disease. FEBS J. 2021, 288:2836-55. 10.1111\/febs.15571","journal-title":"FEBS J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2018.03.012","article-title":"Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer's disease: a focus on human studies","volume":"131","author":"Pistollato F","year":"2018","unstructured":"Pistollato F, Iglesias RC, Ruiz R, et al.. Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer's disease: a focus on human studies. Pharmacol Res. 2018, 131:32-43. 10.1016\/j.phrs.2018.03.012","journal-title":"Pharmacol Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13368-2","article-title":"Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer's disease","volume":"7","author":"Kobayashi Y","year":"2017","unstructured":"Kobayashi Y, Sugahara H, Shimada K, et al.. Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer's disease. Sci Rep. 2017, 7:13510. 10.1038\/s41598-017-13368-2","journal-title":"Sci Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02587-2","article-title":"Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels","volume":"7","author":"Bonfili L","year":"2017","unstructured":"Bonfili L, Cecarini V, Berardi S, et al.. Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels. Sci Rep. 2017, 7:2426. 10.1038\/s41598-017-02587-2","journal-title":"Sci Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2018.1400909","article-title":"Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer's disease-type beta-amyloid neuropathological mechanisms","volume":"18","author":"Ho L","year":"2018","unstructured":"Ho L, Ono K, Tsuji M, Mazzola P, Singh R, Pasinetti GM. Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer's disease-type beta-amyloid neuropathological mechanisms. Expert Rev Neurother. 2018, 18:83-90. 10.1080\/14737175.2018.1400909","journal-title":"Expert Rev Neurother"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2018.12.005","article-title":"Exercise and probiotics attenuate the development of Alzheimer's disease in transgenic mice: role of microbiome","volume":"115","author":"Abraham D","year":"2019","unstructured":"Abraham D, Feher J, Scuderi GL, et al.. Exercise and probiotics attenuate the development of Alzheimer's disease in transgenic mice: role of microbiome. Exp Gerontol. 2019, 115:122-31. 10.1016\/j.exger.2018.12.005","journal-title":"Exp Gerontol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.251","article-title":"Should we standardize the 1,700-year-old fecal microbiota transplantation?","volume":"107","author":"Zhang F","year":"2012","unstructured":"Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation?. Am J Gastroenterol. 2012, 107:1755. 10.1038\/ajg.2012.251","journal-title":"Am J Gastroenterol"},{"key":"ref26","article-title":"The human microbiome handbook","author":"Tetro J","year":"2016","unstructured":"Tetro J, Allen-Vercoe E. The human microbiome handbook. DEStech Publications, Inc.,  Lancaster, PA; 2016."},{"key":"ref27","article-title":"Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis","volume":"44","author":"Eiseman B","year":"1958","unstructured":"Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958, 44:854-9.","journal-title":"Surgery"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1989.tb136704.x","article-title":"Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome?","volume":"150","author":"Borody TJ","year":"1989","unstructured":"Borody TJ, George L, Andrews P, et al.. Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome?. Med J Aust. 1989, 150:604. 10.5694\/j.1326-5377.1989.tb136704.x","journal-title":"Med J Aust"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"van Nood E","year":"2013","unstructured":"van Nood E, Vrieze A, Nieuwdorp M, et al.. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013, 368:407-15. 10.1056\/NEJMoa1205037","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.08.014","article-title":"Treating Clostridium difficile infection with fecal microbiota transplantation","volume":"9","author":"Bakken JS","year":"2011","unstructured":"Bakken JS, Borody T, Brandt LJ, et al.. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011, 9:1044-9. 10.1016\/j.cgh.2011.08.014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2017.1286006","article-title":"Challenges in fecal donor selection and screening for fecal microbiota transplantation: a review","volume":"8","author":"Woodworth MH","year":"2017","unstructured":"Woodworth MH, Carpentieri C, Sitchenko KL, Kraft CS. Challenges in fecal donor selection and screening for fecal microbiota transplantation: a review. Gut Microbes. 2017, 8:225-37. 10.1080\/19490976.2017.1286006","journal-title":"Gut Microbes"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/diseases8020009","article-title":"From donor to patient: collection, preparation and cryopreservation of fecal samples for fecal microbiota transplantation","volume":"8","author":"Nicco C","year":"2020","unstructured":"Nicco C, Paule A, Konturek P, Edeas M. From donor to patient: collection, preparation and cryopreservation of fecal samples for fecal microbiota transplantation. Diseases. 2020, 8:9. 10.3390\/diseases8020009","journal-title":"Diseases"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9061757","article-title":"Fecal microbiota transplantation: screening and selection to choose the optimal donor","volume":"9","author":"Bibb\u00f2 S","year":"2020","unstructured":"Bibb\u00f2 S, Settanni CR, Porcari S, Bocchino E, Ianiro G, Cammarota G, Gasbarrini A. Fecal microbiota transplantation: screening and selection to choose the optimal donor. J Clin Med. 2020, 9:1757. 10.3390\/jcm9061757","journal-title":"J Clin Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30082-0","article-title":"Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel","volume":"5","author":"Ianiro G","year":"2020","unstructured":"Ianiro G, Mullish BH, Kelly CR, et al.. Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel. Lancet Gastroenterol Hepatol. 2020, 5:430-2. 10.1016\/S2468-1253(20)30082-0","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref35","unstructured":"Fecal transplantation for C difficile. a how-to guide. (2013). Accessed: June 07, 2021: https:\/\/www.medscape.com\/viewarticle\/779307."},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2018.08.011","article-title":"Fecal microbiota transplantation: review and update","volume":"118 Suppl 1","author":"Wang JW","year":"2019","unstructured":"Wang JW, Kuo CH, Kuo FC, et al.. Fecal microbiota transplantation: review and update. J Formos Med Assoc. 2019, 118 Suppl 1:S23-31. 10.1016\/j.jfma.2018.08.011","journal-title":"J Formos Med Assoc"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.59","article-title":"Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis","volume":"108","author":"Kassam Z","year":"2013","unstructured":"Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol. 2013, 108:500-8. 10.1038\/ajg.2013.59","journal-title":"Am J Gastroenterol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2017.05.036","article-title":"The 5D framework: a clinical primer for fecal microbiota transplantation to treat Clostridium difficile infection","volume":"87","author":"Allegretti JR","year":"2018","unstructured":"Allegretti JR, Kassam Z, Osman M, Budree S, Fischer M, Kelly CR. The 5D framework: a clinical primer for fecal microbiota transplantation to treat Clostridium difficile infection. Gastrointest Endosc. 2018, 87:18-29. 10.1016\/j.gie.2017.05.036","journal-title":"Gastrointest Endosc"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis809","article-title":"Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection","volume":"55","author":"Zipursky JS","year":"2012","unstructured":"Zipursky JS, Sidorsky TI, Freedman CA, Sidorsky MN, Kirkland KB. Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clin Infect Dis. 2012, 55:1652-8. 10.1093\/cid\/cis809","journal-title":"Clin Infect Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.2302\/kjm.2014-0006-RE","article-title":"Fecal microbiota transplantation for gastrointestinal diseases","volume":"63","author":"Matsuoka K","year":"2014","unstructured":"Matsuoka K, Mizuno S, Hayashi A, Hisamatsu T, Naganuma M, Kanai T. Fecal microbiota transplantation for gastrointestinal diseases. Keio J Med. 2014, 63:69-74. 10.2302\/kjm.2014-0006-RE","journal-title":"Keio J Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2019.04.008","article-title":"The dirty aspects of fecal microbiota transplantation: a review of its adverse effects and complications","volume":"49","author":"Dailey FE","year":"2019","unstructured":"Dailey FE, Turse EP, Daglilar E, Tahan V. The dirty aspects of fecal microbiota transplantation: a review of its adverse effects and complications. Curr Opin Pharmacol. 2019, 49:29-33. 10.1016\/j.coph.2019.04.008","journal-title":"Curr Opin Pharmacol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.60","article-title":"Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection","volume":"107","author":"Brandt LJ","year":"2012","unstructured":"Brandt LJ, Aroniadis OC, Mellow M, et al.. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012, 107:1079-87. 10.1038\/ajg.2012.60","journal-title":"Am J Gastroenterol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.18632\/aging.101464","article-title":"Abnormal gut microbiota composition contributes to cognitive dysfunction in SAMP8 mice","volume":"10","author":"Zhan G","year":"2018","unstructured":"Zhan G, Yang N, Li S, et al.. Abnormal gut microbiota composition contributes to cognitive dysfunction in SAMP8 mice. Aging (Albany NY). 2018, 10:1257-67. 10.18632\/aging.101464","journal-title":"Aging (Albany NY)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.18632\/aging.101978","article-title":"Abnormal gut microbiota composition contributes to cognitive dysfunction in streptozotocin-induced diabetic mice","volume":"11","author":"Yu F","year":"2019","unstructured":"Yu F, Han W, Zhan G, et al.. Abnormal gut microbiota composition contributes to cognitive dysfunction in streptozotocin-induced diabetic mice. Aging (Albany NY). 2019, 11:3262-79. 10.18632\/aging.101978","journal-title":"Aging (Albany NY)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20182386","article-title":"Sex-specific effects of microbiome perturbations on cerebral A\u03b2 amyloidosis and microglia phenotypes","volume":"216","author":"Dodiya HB","year":"2019","unstructured":"Dodiya HB, Kuntz T, Shaik SM, et al.. Sex-specific effects of microbiome perturbations on cerebral A\u03b2 amyloidosis and microglia phenotypes. J Exp Med. 2019, 216:1542-60. 10.1084\/jem.20182386","journal-title":"J Exp Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1080\/09168451.2019.1644149","article-title":"Fecal metabolite of a gnotobiotic mouse transplanted with gut microbiota from a patient with Alzheimer's disease","volume":"83","author":"Fujii Y","year":"2019","unstructured":"Fujii Y, Nguyen TT, Fujimura Y, Kameya N, Nakamura S, Arakawa K, Morita H. Fecal metabolite of a gnotobiotic mouse transplanted with gut microbiota from a patient with Alzheimer's disease. Biosci Biotechnol Biochem. 2019, 83:2144-52. 10.1080\/09168451.2019.1644149","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0525-3","article-title":"Fecal microbiota transplantation alleviated Alzheimer's disease-like pathogenesis in APP\/PS1 transgenic mice","volume":"9","author":"Sun J","year":"2019","unstructured":"Sun J, Xu J, Ling Y, et al.. Fecal microbiota transplantation alleviated Alzheimer's disease-like pathogenesis in APP\/PS1 transgenic mice. Transl Psychiatry. 2019, 9:189. 10.1038\/s41398-019-0525-3","journal-title":"Transl Psychiatry"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520925930","article-title":"Rapid improvement in Alzheimer's disease symptoms following fecal microbiota transplantation: a case report","volume":"48","author":"Hazan S","year":"2020","unstructured":"Hazan S. Rapid improvement in Alzheimer's disease symptoms following fecal microbiota transplantation: a case report. J Int Med Res. 2020, 48:300060520925930. 10.1177\/0300060520925930","journal-title":"J Int Med Res"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/alz.046523","article-title":"Neuroprotective effects of fecal microbiota transplantation in a mouse model of Alzheimer\u2019s disease: development of new models and analysis methods\/validation of pre\u2010clinical methods","volume":"16","author":"Holsinger RD","year":"2020","unstructured":"Holsinger RD, Elangovan S. Neuroprotective effects of fecal microbiota transplantation in a mouse model of Alzheimer\u2019s disease: development of new models and analysis methods\/validation of pre\u2010clinical methods. Alzheimer Dement. 2020, 16:e046523. 10.1002\/alz.046523","journal-title":"Alzheimer Dement"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2018.02.005","article-title":"Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway","volume":"70","author":"Sun MF","year":"2018","unstructured":"Sun MF, Zhu YL, Zhou ZL, et al.. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway. Brain Behav Immun. 2018, 70:48-60. 10.1016\/j.bbi.2018.02.005","journal-title":"Brain Behav Immun"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-019-00719-2","article-title":"Neuroprotection of fasting mimicking diet on MPTP-induced Parkinson's disease mice via gut microbiota and metabolites","volume":"16","author":"Zhou ZL","year":"2019","unstructured":"Zhou ZL, Jia XB, Sun MF, et al.. Neuroprotection of fasting mimicking diet on MPTP-induced Parkinson's disease mice via gut microbiota and metabolites. Neurotherapeutics. 2019, 16:741-60. 10.1007\/s13311-019-00719-2","journal-title":"Neurotherapeutics"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000459","article-title":"Fecal microbiota transplantation associated with 10 years of stability in a patient with SPMS","volume":"5","author":"Makkawi S","year":"2018","unstructured":"Makkawi S, Camara-Lemarroy C, Metz L. Fecal microbiota transplantation associated with 10 years of stability in a patient with SPMS. Neurol Neuroimmunol Neuroinflamm. 2018, 5:e459. 10.1212\/NXI.0000000000000459","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2058272","article-title":"Protection of fecal microbiota transplantation in a mouse model of multiple sclerosis","volume":"2020","author":"Li K","year":"2020","unstructured":"Li K, Wei S, Hu L, et al.. Protection of fecal microbiota transplantation in a mouse model of multiple sclerosis. Mediators Inflamm. 2020, 2020:2058272. 10.1155\/2020\/2058272","journal-title":"Mediators Inflamm"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/63028-fecal-microbiota-transplantation-a-microbiome-modulation-technique-for-alzheimers-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:16Z","timestamp":1707507136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/63028-fecal-microbiota-transplantation-a-microbiome-modulation-technique-for-alzheimers-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":53,"URL":"https:\/\/doi.org\/10.7759\/cureus.16503","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,20]]}}}